Screener
BridgeBio Pharma BBIO Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on trailing twelve months.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's free cash flow margin?
- BridgeBio Pharma (BBIO) reported free cash flow margin of -76.8% in Q1 2026.
- What is the long-term trend for BridgeBio Pharma's free cash flow margin?
- Over 3 years (2021 to 2025), BridgeBio Pharma's free cash flow margin has grown at a -50.5% compound annual growth rate (CAGR), from -733.2% to -89%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about BridgeBio Pharma's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude